Feature | April 02, 2009

McKesson Releases Molecular Diagnostics Criteria Upgrade

April 2, 2009 - McKesson’s releases its 2009 InterQual Criteria and CareEnhance Review Manager 8.0 software features industry-leading innovations including molecular and genetic diagnostics criteria.

The new criteria, combined with the option for clients to access it via McKesson’s recently launched auto authorization capability, is designed to increase the value of the content for users while helping improve quality of care for patients.

“As we bring the latest versions of our criteria and software to market, we are focused on driving efficiencies for payors and providers while expanding into new content areas,” said Tammie Phillips, vice president of InterQual for McKesson Health Solutions. “Even as we address major industry issues with our new auto authorization functionality and molecular diagnostics content, we continue to enhance and add value to the existing elements of our solution suite that have made it the gold standard in evidence-based clinical decision support.”

McKesson’s auto authorization is a hosted, Web-based offering that leverages McKesson’s new Advanced Diagnostics Management solution. The offering automates the entire authorization process, from the initial request all the way through final authorization. McKesson’s auto authorization capability can incorporate InterQual Molecular Diagnostics Criteria and select Imaging Criteria—and soon selected Procedures Criteria—so that medical appropriateness is determined automatically for most requests. The content plus technology drive reduced administrative costs, better payor-provider relations and support optimal care.

The new InterQual Molecular Diagnostics Criteria is an important innovation included in this release. McKesson provides a comprehensive set of criteria to support decision-making for molecular diagnostic tests.

Molecular Diagnostics Criteria is updated quarterly so it is always current. To help healthcare organizations determine test appropriateness based on clinical evidence, InterQual Molecular Diagnostics Criteria covers over 225 tests that comprise approximately 85 percent of the costs in this growing area. A new question and answer format leads to service recommendations that include alternative and concurrent tests, allowing users to easily conduct reviews and act on information. In addition, pop-up notes and clinical evidence summaries drive evidence-based medicine to the point of decision-making with more efficiency. The content is available in CareEnhance Review Manager software as well as McKesson’s Advanced Diagnostics Management solution auto authorization capability.

For more information: www.mckesson.com

Related Content

Improving Molecular Imaging Using a Deep Learning Approach
News | Nuclear Imaging | March 21, 2019
Generating comprehensive molecular images of organs and tumors in living organisms can be performed at ultra-fast speed...
Lucence Diagnostics to Develop AI Tools for Liver Cancer Treatment

Pseudocolor accentuated CT scan image of a liver tumor. Image courtesy of Lucence Diagnostics.

News | Oncology Diagnostics | March 12, 2019
Genomic medicine company Lucence Diagnostics announced a new project to develop artificial intelligence (AI) algorithms...
Amazon Comprehend Medical Brings Medical Language Processing to Healthcare
News | Artificial Intelligence | February 15, 2019
Amazon recently announced Amazon Comprehend Medical, a new HIPAA-eligible machine learning service that allows...
Siemens Healthineers Demonstrates Artificial Intelligence, Healthcare Digitalization at HIMSS19
News | Artificial Intelligence | February 13, 2019
February 13, 2019 — At the 2019 Healthcare Information and Management Systems Society (HIMSS) global conference and e
New Appropriate Use Criteria Outlined for Multimodality Imaging of Nonvalvular Heart Disease
News | Cardiac Imaging | February 11, 2019
The American College of Cardiology (ACC), along with nine other cardiology professional societies, recently published a...
IMS to Unveil Prototype Imaging Machine Learning Platform at HIMSS19
News | Artificial Intelligence | February 06, 2019
International Medical Solutions (IMS) announced a solution that will enable radiologists and other clinicians to use...
News | PET-CT | February 06, 2019
Technological advancements in positron emission tomography/computed tomography (PET/CT) offer both clinicians and pat
Siemens Healthineers Syngo.Breast Care Adding AI-Based Decision Support
News | Clinical Decision Support | February 05, 2019
Siemens Healthineers showcased the new planned artificial intelligence (AI)-based features with its mammography reading...
Infinitt Showcases New RIS/PACS Features at RSNA 2018
News | PACS | December 19, 2018
Infinitt North America highlighted a range of healthcare information technology (IT) products and applications at the...